Ginkgo RNA Therapeutics Services: The versatility of the RNA modality meets the power and flexibility of Ginkgo’s Foundry. Let the data guide you to the optimal RNA therapeutic for your application.
With last year’s acquisition of Circularis, Ginkgo has expanded its platform to screen gene expression regulatory elements in both mRNA and circRNA formats. Partner with Ginkgo to discover sequence elements for improved stability, reduced immunogenicity, improved expression level and cell-type specificity and take advantage of Ginkgo’s end-to-end capabilities to produce your RNA product with high purity.
Learn more at https://www.ginkgobioworks.com/offerings/biopharmaceutical/
